THERAPEUTIC SEGMENT:
Antihypertensive

INDICATIONS:
Indicated in the management of mild to moderate hypertension in patients who are not adequately controlled on monotherapy

BRIEF DESCRIPTION:
CO-Trupril (Lisinopril + Hydrochlorothiazide) combines an Angiotensin converting enzyme inhibitor, Lisinopril and a diuretic, hydrochlorothiazide

DOSAGE FORM:
Tablet (Lisinopril 20mg + Hydrochlorothiazide 12.5mg)